What is the expected benefit of patient-centric clinical development in oncology?

URN to cite this document:: urn:nbn:de:bvb:355-epub-778538
DOI to cite this document:: 10.5283/epub.77853

Serra, Alessandra ; Mozgunov, Pavel ; Jaki, Thomas

; Rigat, Fabio

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 29 Sep 2025 11:38

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

The identification and quantification of predictive biomarkers characterize personalized medicine approaches and patient-centric clinical development. In practice, the sponsor needs evaluating whether biomarker-informed clinical development strategies are more likely to benefit current and future patients. To this end, a simple metric is proposed and assessed here quantifying the expected ...